FindTrial
Sign In

Frequency: Single dose

11 trials

Sponsors

Cadila Healthcare Limited, Intas Pharmaceuticals Limited, Intas Pharmaceuticals Ltd, Ayana Pharma Ltd, PNB Vesper Life Science Pvt Ltd

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 1: C569- Malignant neoplasm of unspecifiedovaryHealth Condition 1: D693- Immune thrombocytopenic purpura

Phase 1

A study to assess Inj. Romiplostim in patients with Low levels of the blood cells that prevent bleeding
RecruitingCTRI/2017/11/010620
Intas Pharmaceuticals LimitedHealth Condition 1: D693- Immune thrombocytopenic purpura
Target: 24Updated: 2021-11-24
A Study of PNB-001 in Healthy, Adult, Human Male Subjects Under Fasting Conditions
Active, not recruitingCTRI/2018/08/015297
PNB Vesper Life Science Pvt Ltd
Target: 42Updated: 2021-11-24
A Study of INTG8 in Healthy Men and Postmenopausal Women
Active, not recruitingCTRI/2018/09/015697
INTAS PHARMACEUTICALS LIMITED
Target: 99Updated: 2021-11-24
A bioequivalence study of a bevacizumab biosimilar in healthy male subjects
Active, not recruitingCTRI/2019/02/017428
Intas Pharmaceuticals Limited
Target: 117Updated: 2021-11-24

Phase 2

How Chewable Calcium Tablets Can Help Reduce Tingling and Numbness During Platelet Donations
Active, not recruitingCTRI/2025/04/084665
Dr Satya Prakash
Target: 326Updated: 2025-04-28

Unknown Phase

A comparative study of Doxorubicin Hydrochloride Injection in the Patients of Ovarian Cancer under fasting conditions
RecruitingCTRI/2017/07/009162
Cadila Healthcare LimitedHealth Condition 1: C569- Malignant neoplasm of unspecifiedovary
Target: 64Updated: 2021-11-24
A Study of Injections of Pegfilgrastim in Healthy, Adult Human Subjects.
Active, not recruitingCTRI/2018/02/011700
Intas Pharmaceuticals Ltd
Target: 144Updated: 2021-11-24
A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects with Ovarian Cancer.
Active, not recruitingCTRI/2018/07/014835
Ayana Pharma LtdHealth Condition 1: C569- Malignant neoplasm of unspecifiedovary
Target: 42Updated: 2021-11-24
A study of recombinant human follicle stimulating hormone (r-hFSH) of Intas Pharmaceuticals Ltd. with Gonal-F in healthy female subjects
Active, not recruitingCTRI/2018/11/016335
Intas Pharmaceuticals Limited
Target: 56Updated: 2021-11-24
A Study of ZOLADEX 3.6 mg in women with advanced Breast Cancer
Active, not recruitingCTRI/2019/03/018338
LONG GROVE PHARMACEUTICALS LLCHealth Condition 1: C509- Malignant neoplasm of breast of unspecified site
Target: 20Updated: 2021-11-24
Booster dose for Covid-19
Active, not recruitingCTRI/2022/02/040563
Asian Healthcare Foundation
Target: 2000Updated: 2022-04-04